MYCN and neuroblastoma: Overall, iron chelators treatment by the novel thiosemicarbazone DpC induces potent cell death of neuroblastoma cells, while targeting some of the major drivers of aggressive neuroblastomas, regardless of their MYCN status (Figure 9).